RSPI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RSPI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Retained earnings is the accumulated portion of net income that is not distributed to shareholders. RespireRx Pharmaceuticals's retained earnings for the quarter that ended in Sep. 2023 was $-177.56 Mil.
RespireRx Pharmaceuticals's quarterly retained earnings declined from Mar. 2023 ($-176.49 Mil) to Jun. 2023 ($-177.17 Mil) and declined from Jun. 2023 ($-177.17 Mil) to Sep. 2023 ($-177.56 Mil).
RespireRx Pharmaceuticals's annual retained earnings declined from Dec. 2020 ($-170.81 Mil) to Dec. 2021 ($-173.96 Mil) and declined from Dec. 2021 ($-173.96 Mil) to Dec. 2022 ($-176.06 Mil).
The historical data trend for RespireRx Pharmaceuticals's Retained Earnings can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RespireRx Pharmaceuticals Annual Data | |||||||||||||||||||||
Trend | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | |||||||||||
Retained Earnings | Get a 7-Day Free Trial | -164.39 | -166.51 | -170.81 | -173.96 | -176.06 |
RespireRx Pharmaceuticals Quarterly Data | ||||||||||||||||||||
Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
Retained Earnings | Get a 7-Day Free Trial | -175.77 | -176.06 | -176.49 | -177.17 | -177.56 |
Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.
Of course, if a company loses, it is called retained losses, or accumulated losses.
RespireRx Pharmaceuticals (OTCPK:RSPI) Retained Earnings Explanation
Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.
For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.
If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.
Of course, many companies with negative retained earnings have indeed lost money in the past.
Retained Earnings: Warren Buffett's Secret.
One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.
If the company loses more than it has accumulated, retained earnings is negative.
If a company isn't adding to its retained earnings, it isn't growing its net worth.
Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.
Microsoft is negative because it chose to buyback stock and pay dividends.
The more earnings retained, the faster it grows and increases growth rate for future earnings.
David Dickason | officer: SVP of Pre-Clinical Prod. Dev. | 126 VALLEY ROAD, SUITE C, GLEN ROCK NJ 07452 |
Timothy L. Jones | director, officer: CEO and President | 126 VALLEY ROAD, SUITE C, GLEN ROCK NJ 07452 |
Manuso James S J | director, officer: President & CEO | 5130 ROUTE 212, WILLOW NY 12495 |
Katie Macfarlane | director | 101 POOR FARM ROAD 3RD FLOOR, PRINCETON NJ 08540 |
Purcell Richard David Jr. | officer: SVP - Research & Deleopment | 65 FAIR HAVEN ROAD, FAIR HAVEN NJ 07704 |
James Sapirstein | director | 1517 SAN JACINTO, HOUSTON TX 77002 |
Marc M Radin | officer: Controller | 33 FRANKLIN PLACE, GLEN ROCK NJ 07452 |
Robert N Weingarten | director, officer: Vice President and CFO | 5439 LOCKHURST DRIVE, WOODLAND HILLS CA 91367 |
Aurora Capital Llc | other: Member of a 10% owner group | 354 WIDOW GAVITS ROAD, PO BOX 1167, BRIDGEHAMPTON, NY 11932-1167 |
Aurora Capital Corp | other: Member of 10% owner group | |
Jeff Eliot Margolis | director, officer: Vice President, Sec. & Treas., other: Member of 10% owner group | C/O AURORA CAPITAL LLC, 17 PARK AVENUE, #201, NEW YORK NY 10016 |
Steven Chizzik | other: Member of 10% owner group | C/O THE VERRAZANO GROUP, LLC, 2204 MORRIS AVENUE, SUITE 203A, UNION NJ 07083 |
Arnold Lippa | director, officer: Chairman, CEO and President, other: Member of 10% owner group | C/O AURORA CAPITAL, LLC, 17 PARK AVENUE, #201, NEW YORK NY 10016 |
T. Morgen Capital Llc | other: Member of 10% owner group | C/O AURORA CAPITAL LLC, 17 PARK AVENUE, #201, NEW YORK NY 10016 |
Kenneth M Cohen | other: Member of 10% owner group | 12750 HIGH BLUFF DRIVE, SUITE 310, SAN DIEGO CA 92130 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 05-24-2022
By Marketwired • 08-09-2023
By Stock market mentor Stock market mentor • 02-01-2023
By Marketwired • 10-12-2023
By PurpleRose PurpleRose • 07-15-2022
By Value_Insider Value_Insider • 11-10-2022
By Stock market mentor Stock market mentor • 01-23-2023
By GuruFocusNews GuruFocusNews • 06-13-2022
By sperokesalga sperokesalga • 03-01-2023
By GuruFocusNews GuruFocusNews • 05-27-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.